Audio and video technology company Dolby Laboratories (NYSE: DLB) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 7.1% year on year to $395.6 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $310 million was less impressive, coming in 9.5% below expectations. Its GAAP profit of $0.99 per share was 7.3% below analysts’ consensus estimates.
Is now the time to buy Dolby Laboratories? Find out by accessing our full research report, it’s free.
Dolby Laboratories (DLB) Q1 CY2026 Highlights:
- Revenue: $395.6 million vs analyst estimates of $385 million (7.1% year-on-year growth, 2.8% beat)
- EPS (GAAP): $0.99 vs analyst expectations of $1.07 (7.3% miss)
- Adjusted Operating Income: $112.9 million vs analyst estimates of $106.1 million (28.5% margin, 6.5% beat)
- The company reconfirmed its revenue guidance for the full year of $1.43 billion at the midpoint
- Operating Margin: 28.5%, in line with the same quarter last year
- Market Capitalization: $6.04 billion
"We continue to strengthen our position and create growth opportunities across existing and new business areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.
Company Overview
Known for its iconic "D" logo that appears before countless movies and TV shows, Dolby Laboratories (NYSE: DLB) designs and licenses audio and video technologies that enhance entertainment experiences in movies, TV shows, music, and other media.
Revenue Growth
A company’s long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Unfortunately, Dolby Laboratories’s 2.1% annualized revenue growth over the last five years was weak. This was below our standards and is a rough starting point for our analysis.
Long-term growth is the most important, but within software, a half-decade historical view may miss new innovations or demand cycles. Dolby Laboratories’s annualized revenue growth of 3.7% over the last two years is above its five-year trend, which is encouraging. 
This quarter, Dolby Laboratories reported year-on-year revenue growth of 7.1%, and its $395.6 million of revenue exceeded Wall Street’s estimates by 2.8%. Company management is currently guiding for a 1.8% year-on-year decline in sales next quarter.
Looking further ahead, sell-side analysts expect revenue to grow 5.6% over the next 12 months. While this projection indicates its newer products and services will catalyze better top-line performance, it is still below the sector average.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
Customer Acquisition Efficiency
The customer acquisition cost (CAC) payback period represents the months required to recover the cost of acquiring a new customer. Essentially, it’s the break-even point for sales and marketing investments. A shorter CAC payback period is ideal, as it implies better returns on investment and business scalability.
Dolby Laboratories’s recent customer acquisition efforts haven’t yielded returns as its CAC payback period was negative this quarter, meaning its incremental sales and marketing investments outpaced its revenue. The company’s inefficiency indicates it operates in a highly competitive environment where there is little differentiation between Dolby Laboratories’s products and its peers.
Key Takeaways from Dolby Laboratories’s Q1 Results
It was encouraging to see Dolby Laboratories beat analysts’ revenue expectations this quarter. On the other hand, its revenue guidance for next quarter missed. Overall, this was a softer quarter. The stock traded down 6.9% to $59.75 immediately following the results.
Dolby Laboratories’s latest earnings report disappointed. One quarter doesn’t define a company’s quality, so let’s explore whether the stock is a buy at the current price. We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).
